Evidence map›Paper›PMID 37431466›Full record

ArticlePeerJ2023

Some structural features of the peptide profile of myelin basic protein-hydrolyzing antibodies in schizophrenic patients.

Maria Zavialova, Daria Kamaeva, Laura Kazieva, Vladlen S Skvortsov, Liudmila Smirnova

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. New Sight: Enzymes as Targets for Drug Development.Current issues in molecular biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria Zavialova *Institute of Biomedical Chemistry, Moscow, Russia.
Daria Kamaeva *Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Laura KazievaInstitute of Biomedical Chemistry, Moscow, Russia.
Vladlen S SkvortsovInstitute of Biomedical Chemistry, Moscow, Russia.
Liudmila SmirnovaMental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Institute of Biomedical Chemistry · RUTomsk National Research Medical Center · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibodies of schizophrenic patients that hydrolyze myelin basic protein (MBP) have been actively studied recently, but the mechanism of the catalytic properties of immunoglobulin molecules remains unknown. Determination of specific immunoglobulin sequences associated with the high activity of MBP proteolysis will help to understand the mechanisms of abzyme catalysis. In the course of comparative mass spectrometric analysis of IgG peptides from the blood serum of patients with acute schizophrenia and healthy people, 12 sequences were identified, which were found only in antibodies that hydrolyze MBP. These sequences belong to IgG heavy chains and

Indexed as

Antibodies, CatalyticMyelin Basic ProteinCatalysisHumansImmunoglobulin GImmunoglobulin lambda-ChainsPeptidesAntibodies, CatalyticImmunoglobulin GImmunoglobulin lambda-ChainsMyelin Basic ProteinPeptidesAbzymesMyelin basic proteinProteomicsSchizophrenia

Identifiers

PMID37431466
PMCPMC10329820
OpenAlexW4383375670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.